GlassScriptPhysician profile
Chanda Richele Anderson
NPI 1508401548
$3,473.90
in general payments reported to CMS, 2019-2025
40 companies · $801 in 2025
The $801 reported for 2025 was more than what 83% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $918 · 2022: $556 · 2023: $564 · 2024: $634 · 2025: $801.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,000.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,999.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $874.93 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $451.44 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Pfizer INC. | $267.39 | 2021-2025 | |
| Amgen INC. | $174.72 | 2021-2023 | Repatha, Otezla |
| Novo Nordisk INC | $152.70 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Nestle Healthcare Nutrition INC. | $135.71 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $129.51 | 2023-2025 | Xifaxan |
| Amarin Pharma, INC. | $124.93 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $124.42 | 2022-2025 | Rexulti |
| Lilly USA, LLC | $95.65 | 2021-2025 | Mounjaro, Jardiance |
| Merck Sharp & Dohme LLC | $91.48 | 2022-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Daiichi Sankyo INC. | $86.59 | 2021-2024 | Injectafer |
| Bayer Healthcare Pharmaceuticals INC. | $60.30 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $55.00 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $51.68 | 2025 | Caplyta |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chanda Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.